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E-mail address: jfzhang@mail.njust.edu.cn (J. ZhanThe existence of peripheral oscillators has been shown, and they are critically important for organiz-
ing the metabolism of the whole body. Here we show that mice deﬁcient in mPer2 markedly
increase circulatory levels of insulin compared with wild type mice. Insulin secretion was more
effectively stimulated by glucose, and alloxan, a glucose analogue, induced more severe hyperglyce-
mia in mPer2-deﬁcient mice. Hepatic insulin degrading enzyme (Ide) displayed an obvious day and
night rhythm, which was impaired in mPer2-deﬁcient mice, leading to a decrease in insulin clear-
ance. Deﬁciency in mPer2 caused increased Clock expression and decreased expression of Mkp1
and Ide1, possibly underlying the observed phenotypes and suggesting that mPer2 plays a role in
regulation of circulating insulin levels.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Insulin is a polypeptide hormone which is essential for the
regulation of glucose metabolism, and is synthesized exclusively
in b cells of the islets and degraded mainly in liver and kidney
[1–2]. Circulating insulin affects many areas of metabolism,
including carbohydrate, lipid, protein and mineral metabolism
[3]. Insulin facilitates entry of glucose into muscle, adipose and
several other tissues and stimulates liver to store glucose in the
form of glycogen. Insulin decreases production of glucose from
non-sugar substrates, promoted synthesis of fatty acids in the li-
ver and inhibits breakdown of fat in adipose tissue. Gene-muta-
tion and knockout models have identiﬁed that plasma insulin
levels are regulated by insulin secretion and clearance [4–6]. It
is well known that glucose stimulates insulin secretion, which
is modulated by pancreatic glucose transporter 2 (Glut2) level.
Mice lacking a functioning Glut2 gene manifest hypoinsulinemia
[4]. Insulin-degrading enzyme (Ide) is widely recognized as the
principal protease responsible for the clearance of insulin. Mice
deﬁcient in Ide markedly increase levels of serum insulin [5].
Both the processes of insulin secretion and degradation are
circadian controlled [7–13]. Several studies demonstrate thatchemical Societies. Published by E
lecular Metabolism, Nanjing
ei, Nanjing, China. Fax: +86
g).insulin-producing beta cells of islets among the pancreatic cell-
types possess an intrinsic clock and a rhythmic pattern of the
insulin secretion rates have been identiﬁed [7–12]. Human insulin
secretion rates change in a circadian rhythm during 24 h [10,11].
Moreover, a circadian regulation of feeding-induced insulin re-
sponses is observed in rat, which is independent of the temporal
distribution of feeding activity [12]. The diurnal variation in insu-
lin clearance rate is also described in previous work. Human insu-
lin clearance rate is signiﬁcantly higher in the evening than in the
morning [13].
The clock gene mPer2 is an important component of the circa-
dian system, both in the brain and in peripheral tissues [14,15].
Its functions are involved in a number of regulations of different
biological process and pathways [16–19]. Mice deﬁcient in mPer2
reduced endurance of muscles accompanied by increased levels of
glycolytic enzymes in the anterior tibialis muscle, indicating a
greater dependence on anaerobic metabolism under stress condi-
tions [16]. Also, mPer2 mutant mice display altered lipid metabo-
lism with a remarkable reduction in body weight and epididymal
fat pad mass by direct regulation of PPARc [17].
Whether mPer2 inﬂuences insulin secretion and its action re-
mains unclear. Here, we showed that plasma insulin levels were
elevated in mPer2-deﬁcient mice, which was associated with en-
hanced glucose-stimulated insulin secretion and impaired insulin
clearance. Our ﬁndings suggested mPer2 played a role in regula-
tion of circulatory insulin levels.lsevier B.V. All rights reserved.
Table 1
Primer sequences for relative genes.
Gene Forward primer Reverse primer
Glut2 CTGGGTCTGCAATTTTGTCA TGTAAACAGGGTGAAGACCA
Ide GGGAAATCATCTCGCAGCAGT TGGCGCTTCGGACAA GTTTAT
Mkp1 TGCCTGACAGTGCAGAATCC TCCTTCCG AGAAGCGTGATAG
Clock CGGCGAGAACTTGGCATT AGGAGTTGGGCTGTGATCA
b-Actin GATCATTGCTCCTCCTGAGC ACTCCTGCTTGCTGATCCAC
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2.1. Animal
The mPer2-deﬁcient mice used in this study were kindly pro-
vided by Dr. Lee CC [18], and were bred onto the C57BL/6J (Jackson
Laboratory, Bar Harbor, ME, USA) background for eight to ten gen-
erations (N8 to N10), according to standard genetic protocols. Age
and gender matched C57BL/6J animals were used as controls in all
experiments. All the mice were housed in a standard animal main-
tenance facility under a 12-h/12-h light/dark cycle, and with free
access to regular chow food and given access to standard mouse
chow and water ad libitum, except when overnight fasting was
required. The experiments were performed under protocols
approved by the institutional animal care committee of NJUST.
2.2. Plasmid, primers and regents
All the primers were synthesized by Invitrogen (USA). D-glu-
cose, insulin, glycogen, alloxan, L-alanine, sodium pyruvate and
all inorganic salts were purchased from Sigma Inc (USA). mPer2
cDNA Plasmids were kindly provided by Dr. Lee CC. Glycogen assay
kit was purchased from Nanjing Jiancheng Bioengineering Insti-
tute. (China). Cell culture reagents were purchased form Thermo
Fisher Scientiﬁc Inc (USA). MMLV reagent was purchased from
Takara Bio Inc (Japan). SYBR Green Realtime PCR Master Mix was
purchased from Toyobo Inc (Japan). Iodine [125I] Insulin Radioim-
munioassay Kit was purchased from Beijing Chemclin Biotech
Co., Ltd. (China).
2.3. Glucose tolerance, insulin sensitivity and insulin secretion tests
For glucose tolerance, mice were fasted 14 h and then injected
intraperitoneally (i.p) glucose 2 g/kg body weight at Zeitgeber time
(ZT)2 and ZT14. Total blood glucose was determined before and
after injection by One Touch Blood Glucose Meter (AW063-436-
01A), (LifeScan InC) using 3 ll of whole blood obtained by tail
bleed at 0, 30, 60, and 120 min. For glucose stimulated insulin
secretion, glucose (2 g/kg of body weight) was injected i.p and ve-
nous blood was collected at 0, 15, 30 and 120 min. Plasma was sep-
arated and frozen in aliquots and stored at 20 C. Plasma insulin
was measured using radioimmunoassay by commercial Iodine
[125I] Insulin Radioimmunioassay Kit. For insulin sensitivity test,
mice were fasted for 14 h and injected i.p with regular insulin
(100 U/ml) resulting in a ﬁnal concentration of 0.125 U/kg body
weight. Blood was collected at 0, 30, 60 and 180 min after the
injection and measured by One Touch Blood Glucose Meter.
2.4. Histologic analyses
Pancreas from abdominal region were ﬁxed in 10% neutral buf-
fered formalin for 24 h and then processed in 70% alcohol for his-
tological analysis. Tissues were embedded in parafﬁn and 8 lm
sections were cut and stained with hematoxylin and eosin stain
(H&E) procedures. Estimation of islet number was performed by
counting the number of islets per 10 lm section of four to seven
sections per mouse, using three mice per genotype. The circling
islet area and the area of each section were determined with the
BioQuant image analyzer software package.
2.5. Determination of hepatic glycogen content
Mice were fasted 14 h and then injected intraperitoneally
glucose 2 g/kg body weight at ZT2. Mice were killed at the indicted
time by cervical dislocation or decapitation. Liver were rapidlyexcised, quick-frozen in liquid nitrogen, and stored at 80 C. Glu-
cogen contents were determined using glucogen assay kit.
2.6. Gluconeogenesis analysis
Gluconeogensis analysis was performed as previously reported
[20]. WT and mPer2-deﬁcient mice were fasted 14 h and then in-
jected 200 mg/kg L-alanine and 500 mg/kg sodium pyruvate at
ZT2. Tail-vein blood samples were assessed for glucose concentra-
tion at the indicated time points (0, 15, 30, 45 and 60 min).
2.7. Alloxan treatment
WT and mPer2-deﬁcient mice were fasted overnight (14 h) and
then inject intraperitoneally at low dose (140 mg/kg) of alloxan. To
assess the onset and severity of the diabetes, blood glucose levels
from tail blood were measured 3th days after the initial injection.
Total blood glucose was determined after fasting overnight.
2.8. Cell culture and plasmid transfections
HepG2 cell was maintained in DMEM supplemented with anti-
biotics. and 15% fetal calf serum in an atmosphere of humidiﬁed
95% air and 5% CO2 at 37 C. The cells were transfected with the
mPer2 cDNA plasmids indicated using transfection reagent
(Lipofectamine 2000 Reagent, Invitrogen). Cells were prepared
24 h later for extracting total RNA and examination of Ide, Mkp1
and Clock expression by real time RT-PCR.
2.9. Quantitative real time RT-PCR
Total RNA was extracted from the fresh liver and cell samples
with Trizol Reagent. Islets were isolated by collagenase digestion
using the protocol [21] and total mouse islet RNA was extracted
as described [22]. RNA was reverse-transcribed with poly (dT)12–
18 as a ﬁrst-strand primer according to the manufacturer’s instruc-
tions. Real-time PCRwas performed and analyzed using an ABI 7300
Detection System in combination with SYBRgreen dye. The primers
details and reaction conditions can be seen in Table 1. Relative
expression in comparison with b-Actin was calculated by the com-
parative CT method.
3. Results
3.1. Elevation of plasma insulin level in mPer2-null mice
We measured insulin level in plasma samples collected from
wild type (WT) and mPer2-null mice. As shown in Fig. 1A, The ser-
um insulin level ofmPer2-null mice was about 1.5-fold higher than
WT mice while fasted for 14 h (0 point in Fig. 1A). Next we exam-
ined the glucose stimulated insulin secretion. At 15 min and
30 min after i.p. glucose injection, plasma insulin levels increased
signiﬁcantly more in mPer2-null mice compared with WT mice.
Plasma insulin level returned to pre-injection levels at 120 min
in both genotypes. GTT tests were then carried out in both WT
WT
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Fig. 1. Elevated plasma insulin levels and increased glucose-stimulated insulin secretion in mPer2-null mice. (A) Plasma insulin levels at the indicated times before and after
glucose administration. (B) Glucose tolerance tests GTT after i.p loading with 2 g D-glucose/kg were performed on 8-week-old male animals of the indicated genotypes
following a 14-h fast at ZT2. (C) Glucose tolerance tests at ZT14. Data were all shown as the mean ± S.E.M. (n = 5). ⁄P < 0.05, ⁄⁄P < 0.01.
1308 Y. Zhao et al. / FEBS Letters 586 (2012) 1306–1311and mPer2-null mice at ZT2 (Fig. 1B) and ZT14 (Fig. 1C), and the
mPer2-null mice displayed lower blood glucose levels compared
with WTmice, which was correlated with the plasma insulin levels
at the same time points after glucose stimulation, indicating an in-
crease in plasma insulin level and glucose utilization in mPer2-null
mice.
3.2. Increased Glucose transporter 2 (Glut2) gene expression in mPer2-
null mice
To further analyze the factors contributing to enhance glucose-
stimulated insulin secretion in mPer2-null mice, we analyzed the
islet histology. Pancreatic islets of mPer2-null mice were indistin-
guishable in appearance from those of WT mice (Fig. 2A) and no
signiﬁcant difference was found between two genotypes in the
numbers of islets (Fig. 2B) and mean size of islets (Fig. 2C). Thus
it was unlikely that islet development reﬂected increased glu-
cose-stimulated insulin secretion inmPer2-null mice. Then we ana-
lyzed the mRNA levels of Glut2 in the isolated pancreatic islets. The
quantitative RT-PCR showed that Glut-2mRNAs of pancreatic islets
were markedly increased in the mPer2-null mice compared with
WT mice (Fig. 2D). Alloxan is a toxic glucose analogue that prefer-
entially accumulates in pancreatic beta cells via Glut2-dependent
transport and is used to induce hyperglycemia. We exposed allox-
an (140 mg/kg body weight) to WT and mPer2-null mice, respec-
tively. As shown in Fig. 2E, the mPer2-null mice responded with
more severe hyperglycemia compared to the wild type controls.1
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Fig. 2. Increased Glut2 expression in pancreatic islets of mPer2-null mice. (A) Pancreat
hematoxylin and eosin stain (H&E) procedures, and sections were analyzed using light m
(B) The number of Islets enumerated from microscopic examination of histological sect
10 lm of four to seven sections per mouse. (C) The islet area was measured by circling is
null mice. (E) Plasma glucose level after injection of alloxan. Data were all shown as theThese results reveal that enhanced glucose-stimulated insulin
secretion is associated with increased Glut2 expression in pancre-
atic islets of mPer2-null mice.
3.3. Impaired hepatic insulin degrading enzyme (Ide) gene expression
and decreased insulin clearance in Per2-null mice
Reduced insulin clearance also led to elevated levels of circulat-
ing insulin, so we next examine insulin clearance inWT andmPer2-
null mice. Insulin tolerance tests were carried out in mPer2-null
and compared withWTmice. As shown in Fig. 3A, after an i.p injec-
tion of insulin solution at a dose of 0.125U /kg of body weight, the
systemic glucose levels in WT mice andmPer2-null mice were both
signiﬁcantly reduced. The mPer2-null mice had similarly reduced
levels of blood glucose levels 15 min post-injection, suggesting
that mPer2-null mice had normal insulin sensitivity. However, de-
layed glucose recovery after insulin-induced hypoglycemia was
observed in mPer2-null mice at subsequent time points. These re-
sults suggest that excessive insulin is still not degraded in
mPer2-null mice and mPer2-null mice decrease the rate of insulin
clearance (Fig. 3A). Then, we extracted liver total RNA from both
genotype mice at ZT4 and ZT16 for checking hepatic Ide expression,
which can contribute to insulin clearance. Interestingly, Ide mRNA
expression had an obvious day and night rhythm (Fig. 3B), which
was similar pattern tomPer2mRNA expression. InmPer2-null mice
Ide levels were signiﬁcantly lower compared to WT mice at both
ZT4 and ZT16 (Fig. 3B); the mRNA of Clock and clock-controlledWT mPer2-null
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Fig. 3. Loss of mPer2 resulted in decreased insulin clearance. (A) The decline in blood glucose from basal levels of mice was monitored following injections with 0.125 units/
kg insulin. (B)Comparison of relative level of Ide, (C) Clock and (D) Mkp1 mRNA assessed by real-time RT-PCR in liver of mPer2-null and WT mice at ZT4 and ZT16. (E)
Quantitative real time RT-PCR was performed to assay Ide, (F)Mkp1 and (G) ClockmRNA levels. HepG2 cell lines were transfected withmPer2 cDNA plasmid for 24 h. Relative
expression in comparison with b-Actin was calculated by the comparative CT method. Data were all shown as the mean ± S.E.M. (n = 4–8) ⁄P < 0.05, ⁄⁄P < 0.01.
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higher levels in mPer2-null livers than WT livers (Fig. 3C and D).
TransfectingmPer2 cDNA into culture cell lines resulted in increase
in Ide expression (Fig. 3E), and a decrease in expression of Mkp1
and Clock mRNA (Fig. 3F and G).
3.4. Increased liver glycogen levels and impaired gluconeogenesis in
mPer2-null mice
Elevated circulatory insulin levels results in increased liver gly-
cogen synthesis. Therefore we examined liver glycogen in mPer2-
null and wild type mice, respectively. As shown in Fig. 4A,
mPer2-null mice have increased liver glycogen both under fastingWT
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Fig. 4. Increased liver glycogen content and impaired hepatic gluconeogenesis in mPer2-
glucose injection (60 min). (B) 14 h fasted WT andmPer2-null mice each received an i.p. in
samples were assessed for glucose concentration immediately before injection (time
mean ± S.E.M. (n = 4–6). ⁄P < 0.05, ⁄⁄P < 0.01.conditions and in response to a bolus of injected glucose. Insulin
was also the most important hormone that inhibits gluconeogene-
sis. Injection of L-alanine and sodium pyruvate was performed to
examine gluconeogenic capacity in WT and mPer2-null mice. As
shown in Fig. 4B and C,mPer2-null mice displayed a lesser increase
in blood glucose in response to pyruvate or alanine injection
compared to WT mice, implying that hepatic gluconeogenesis
was impaired in mPer2-null mice.
4. Discussion
Several investigations have demonstrated that circadian sys-
tem plays an important role in glucose metabolism [7,8,23,24].C
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1310 Y. Zhao et al. / FEBS Letters 586 (2012) 1306–1311Clock mutant mice display signiﬁcantly elevated fasting glucose
levels and impaired glucose tolerance [8]. Mice deﬁcient in Bmal1
also exhibit impaired glucose tolerance and abolished hepatic glu-
coneogenesis [8,23,24]. Both Clock and Bmal1 mutant mice exhibit
impaired glucose-stimulated insulin secretion [7,8]. In our pres-
ent study, mice lacking in mPer2 resulted in elevation of plasma
insulin level, which increased glucose utilization and impaired
gluconeogenesis. On the contrary to Clock and Bmal1 knock out
mice, loss of mPer2 function in the mice enhanced glucose-stim-
ulated insulin secretion. It is well known mPer2 is driven by the
basic helix–loop–helix–PAS protein (Clock-Bmal1) complex,
which binds the E-box on the genes, and this Clock-Bmal1-med-
iated transcription is in turn repressed by PER2 etc. complexes
that translocate to nuleus [25,26]. Thus, loss of mPer2 function
could result in enhanced Clock and Bmal1 expression and in-
creased the activation of Clock-Bmal1-mediated transcription,
displaying a reverse effect on glucose-stimulated insulin secretion
compared to Clock and Bmal1 deﬁcient mice. Strangely, double
knockout of mPer1/, mPer2/ mice in a pure 129Sv/Ev genetic
background were observed to impair glucose tolerance [23]. This
difference could be due to the different genetic backgrounds or to
the additional loss of mPer1.
Expression of mPer2 is dampened in livers of insulin deﬁcient
mice (STZ-treated), which is normalized by injection of insulin
[27]. In WT mice, insulin injection during the daytime causes a
phase advance of hepatic mPer2 expression rhythm, and insulin
infusion induced an acute increase of mPer2 gene expression and
a similar phase advance ofmPer2 expression rhythm in vitro exper-
iment [28]. Data presented here reveal that loss ofmPer2 increased
plasma insulin level by increased pancreatic Glut2 expression and
enhanced glucose-stimulated insulin secretion. These ﬁndings sug-
gest the existence of a crosstalk between insulin secretion and
mPer2 expression.
Plasma insulin level is also regulated by hepatic Ide expression [2].
Ide- deﬁcient mice display hyperinsulinemia [5]. In vitro, Ide gene
expression is decreased by inhibiting phosphor-mitogen-activated
protein kinase (phospho-MAPKs) signal transduction pathways [29].
MAP kinase phosphatase 1 (MKP1), a negative regulator for MAPK-
mediated signal transduction, is a Clock-controlled gene expressed
in the central pacemaker neurons of the hypothalamic SCN [30]. Our
results demonstrated loss of mPer2 decreased hepatic Ide expression,
which was related to increase Clock and its controlled gene Mkp1
expression. High plasma insulin level is a risk factor for several dis-
eases [31–33]. Elevated insulin levels are associated with hypoglyce-
mia, cancer and vessel disease. mPer2-null and Per2m/m mice suffer
multiple abnormalities, including increased carcinogenesis and im-
paired vascular endothelial function [34–36]. Elevated plasma insulin
could play a partial role in multiple abnormalities in mPer2-deﬁcient
mice.
In summary, lack ofmPer2 elevated plasma insulin levels, which
was associated with enhanced glucose-stimulated insulin secre-
tion and impaired insulin clearance.Acknowledgements
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